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Abstract
Background: Commercial swine breeds in North America undergo two waves of spontaneous fetal loss; one
during peri-attachment and another during mid-gestation. Although an exact mechanism for this loss is not
known, deficits in vasculature at the attachment sites appear to be a major cause. We hypothesized that a balance
between pro-angiogenic and anti-angiogenic factors is needed at the maternal-fetal interface for successful
conceptus development. Six selected members of the pro-angiogenic fibroblast growth factor (FGF) and platelet
derived growth factor (PDGF) families and anti-angiogenic factor thrombospondin-1 (TSP-1) and its receptor CD36
were quantified and localized at the porcine maternal-fetal interface at early and midgestation time points.
Methods: Mesometrial endometrium was collected from non-pregnant gilts (n = 8). Endometrial and
chorioallantoic membrane samples were collected from healthy and arresting conceptus attachment sites at
gestation day (gd) 20 (n = 8) and gd 50 (n = 8). At gd20 arresting conceptus attachment sites were distinguished
by decreased vasculature of the placental membranes and decreased conceptus size. At gd50 arresting
conceptuses attachment sites were identified by smaller conceptus length and weight measurements. Quantitative
real time PCR was used to determine relative transcript levels of genes of interest, and cellular localization was
determined by immunohistochemistry in paraffin embedded endometrial sections.
Results: At gd20, endometrial samples from arresting conceptuses had elevated transcripts for bFGF, and PDGF-bb
than healthy sites (p < 0.05). At gd50, bFGF, FGFR2, and CD36 were more abundant at arresting than at healthy
conceptus attachment sites (p < 0.05). Chorioallantoic membrane from arresting conceptus attachment sites at
gd20 had elevated transcripts for bFGF, FGFR1, FGFR2 and CD36 compared with healthy sites (p < 0.05). FGFR2
transcripts were more abundant in chorioallantoic membrane from arresting conceptuses at gd 50 (p < 0.05).
Immunohistochemical localization of selected pro- and anti-angiogenic factors and receptors revealed their
abundance in the luminal epithelium, uterine glands and perivascular areas of endometrium at gd20 and gd50.
Conclusions: We provide comprehensive analysis of pro and anti-angiogenic factors at the porcine maternal fetal
interface during early and mid-pregnancy. At mRNA levels, the majority of pro-angiogenic factors investigated were
elevated at the sites of fetal arrest. These observations contrast with our previous findings of decreased Vascular
Endothelial Growth Factor (VEGF) family members at arresting sites, and suggest that the bFGF family functions as
a compensatory survival mechanism when major angiogenic proteins are decreasing at the sites of fetal arrest.
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Prenatal mortality is a prime concern for commercial
pork industry in North America. Thirty to forty percent
of conceptuses are lost during gestation [1]. This sponta-
neous fetal loss is found in two waves, a peri-attachment
wave of conceptus loss (gd 10-30) and a mid gestational
wave of fetal loss (gd 50-70) [1-4]. Since only 1.3% of
conceptuses have a gross chromosomal abnormality, con-
c e p t u sg e n e t i c si su n l i k e l yt oa c c o u n tf o rm o r et h a na
minor proportion of the fetal losses [5]. Although exact
mechanisms for the fetal loss are still unknown, angio-
genesis appears to be crucial in successful development
of conceptuses through gestation.
Angiogenesis is defined as the formation of blood ves-
sels from pre-existing blood vessels. Swine, a species
with an epitheliochorial form of placentation, undergo
extensive angiogenesis at the maternal-fetal interface to
meet the nutrient requirements of the developing con-
ceptus [6]. Investigations of the porcine maternal-fetal
interface at time points representative of the peri-
attachment [3,4,7] and mid-gestational [7] stages of con-
ceptus loss showed that conceptuses undergoing growth
arrest had decreased endometrial vasculature compared
to their healthy counterparts. We postulate that a deficit
in vascular development at the maternal-fetal interface
may play a participatory role in the conceptus loss that
occurs during porcine pregnancy. Previously, we have
reported decreased transcripts of the prime pro-angio-
genic molecule VEGF and two of its receptors, VEGFRI
and VEGFRII, in endometrial lymphocytes, endome-
trium and trophoblast associated with arresting concep-
tus attachment sites [3,4,7]. Although there was no
direct evidence that the arresting conceptuses identified
at early or mid-gestation will be lost later during gesta-
tion, our studies provided first evidence [3,4,7] that dys-
regulation in angiogenesis at the maternal-fetal interface
is a prime cause leading to growth arrest of developing
conceptuses. Given that angiogenesis is a complex pro-
cess which is regulated through a number of alternate
pathways, we extended our investigations of the mater-
nal-fetal interface in relation to pregnancy success or
failure.
Basic Fibroblast Growth Factor (bFGF) is a pro-angio-
genic molecule, a potent mitogen of endothelial cells and
provides the initial stimulus needed for angiogenesis [8].
It is highly expressed in endometrium during rat, human
and primate pregnancy [9-12]. In porcine endometrium,
bFGF and its two angiogenic receptors (FGFR1 and
FGFR2) are expressed at the beginning of pregnancy
(gd10) when extensive angiogenesis is occurring [13].
Basic fibroblast growth factor and FGFR1 are localized in
the luminal epithelium, stroma and glands in porcine
endometrium [13-15]. FGF-9 is highly upregulated in
pregnant porcine endometrium, and its localization to
the glandular epithelium indicates it could act as an
important embryonic growth factor [16].
Platelet derived growth factor-bb, another pro-angio-
genic growth factor, can stimulate endothelial cells to
form nascent vascular networks and recruit mural cells
to stabilize developing blood vessels [17,18]. PDGF-bb’s
two main angiogenic receptors, PDGFRa and PDGFRb,
are involved in different aspects of angiogenesis;
PDGFRa in the stimulation of endothelial cells, and
PDGFRb in the recruitment of mural cells [19,20]. Dur-
ing pregnancy, PDGFs are actively expressed on both
sides of the maternal-fetal interface in humans [21,22].
Platelet Derived Growth Factor-bb and PDGFRb play an
essential role in normal murine placental development.
Knockouts for either show abnormal labyrinthine forma-
tion, reduced labyrinthine trophoblast, and inherently
dilated blood vessels that lack pericytes [19,20,23]. Dis-
tribution of PDGFRa and b has been well characterized
[24] at the porcine maternal-fetal interface at the begin-
ning of pregnancy (gd7-12).
Thrombospondin-1 (TSP-1) is a potent anti-
angiogenic factor and effects angiogenesis by directly
binding CD36 expressed on endothelial cells, as well as
through growth factors, cytokines and proteases [25].
Thrombospondin-1 has the ability to inhibit endothelial
cell DNA synthesis, leaving the cells unable to prolifer-
ate [26]. Thrombospondin-1 can directly bind VEGF,
leading to internalization through the low density lipo-
protein receptor-1 receptor [27]. Thrombospondin-1
also regulates the activity and bioavailability of matrix
metalloproteinases, which in turn, regulate VEGF bioa-
vailability by releasing matrix bound VEGF [28]. In
humans, TSP-1 is expressed by endometrial stromal
cells [29]. CD36, the primary TSP-1 anti-angiogenic
receptor, is also expressed in human endometrium [30].
Thrombospondin-1 and CD36 have never been investi-
gated at the maternal-fetal interface of a species with
epitheliochorial placentation.
The purpose of this study was to determine whether
changes in pro- and anti-angiogenic factors are asso-
ciated with spontaneous fetal loss in North American
swine. We hypothesized that a balance between pro-
angiogenic (FGF and PDGF family members) and anti-
angiogenic factors (TSP-1 and CD36) is required at the
porcine maternal-fetal interface to promote successful
conceptus development.
Methods
Porcine tissue sample collection
Porcine endometrial and chorioallantoic membrane
samples were obtained from specific pathogen-free
Yorkshire gilts housed at the Arkell Swine Research
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gilts were slaughtered and uteri collected from non-
pregnant (NP) (n = 8, diestrus), gd20 (n = 8) and gd50
(n = 8) stages. Immediately following slaughter, uteri
were transported on ice, to an RNAse decontaminated
laboratory. Random samples of mesometrial endome-
trium were collected from non-pregnant uteri. At gd20
and gd50, healthy and arresting littermates were identi-
fied and endometrial and chorioallantoic membrane
samples were taken from the attachment sites [3,4,7].
Arresting conceptuses were identified by decreased size
and lower placental vascularity at gd20, and decreased
conceptus length and weight measurements at gd50 [3].
Samples were collected from three healthy attachment
sites, and all arresting conceptus attachment sites per
uterus. Each sample was divided into three portions; one
was snap-frozen at -80°C for RNA and protein extraction,
another was frozen at -80°C in OCT cryomatrix for cryo-
sectioning, and the last was placed in 4% paraformalde-
hyde for paraffin embedded immunohistochemistry.
RNA extraction from endometrial and chorioallantoic
membrane samples
RNA extraction was performed using RNAeasy Mini Kit
(Qiagen Sciences, Mississauga, ON, Canada) as per
manufacturer’s instructions. Thirty mg of tissue was dis-
rupted and homogenized with Buffer RLT provided with
the kit containing b-mercaptoethanol in a microcentri-
fuge tube. A rotor-stator homogenizer was used to dis-
rupt the tissue (Fisher Scientific, Ottawa, ON). The
lysate was centrifuged and 600 μL of 70% ethanol was
added to the supernatant. Samples were loaded onto
RNAeasy spin columns and centrifuged for 15 seconds.
After two washings of spin columns with wash buffer
provided with the kit, purified RNA was eluted by add-
ing 30 μL of RNAase/DNAase free water. The Gene
Quant Pro RNA/DNA calculator (Biochrome IDD,
Cambridge, MA) was then used to measure RNA con-
centration. RNA was immediately put through first
strand cDNA synthesis, or frozen at -80°C for subse-
quent use.
cDNA synthesis
cDNA synthesis was performed using First-Strand cDNA
Synthesis Kit as per manufacturer’si n s t r u c t i o n s( G E
Healthcare, Buckinghamshire, UK). RNA (1.5 μgi n
20 μL) heated at 65°C for 10 minutes in GeneAMP PCR
System 2700 (Applied Biosystems, Foster, CA). To this,
11 μL of the bulk first strand cDNA reaction mix, 1 μL
of DTT solution and 1 μL of poly(dT) primer was added.
The sample was incubated for 60 minutes at 37°C in the
PCR machine. The cDNA was stored in -20°C for future
use as a template for real time polymerase chain reaction.
Quantitative real-time PCR
Primers were designed based on coding sequence
homology from different mammalian species (human,
mouse, rat, cow, horse and dog) usingPrimer3
http://frodo.wi.mit.edu/primer3/ program. Target genes
were amplified from pooled porcine reproductive tissue
cDNA with Quantitect SYBR Green I PCR mix (Qiagen)
on real-time capillary based PCR system (LightCycler,
Roche Diagnostics, Laval, QC). Amplification product
was sequenced to confirm that primers were amplifying
target genes. Following confirmation that primer sets
were amplifying desired genes, relative quantification
with b-actin as a housekeeping gene was performed
using the LightCycler480 (Roche Diagnostics, Laval,
QC). Data were analyzed using LightCycler480 RelQuant
software.
Immunohistochemistry in paraffin embedded porcine
endometrial sections
Paraffin-embedded endometrial sections were cut at 7
μm and placed on positively charged microscope slides
(Superfrost Plus, Fisher Scientific, Ottawa, ON). Sec-
tions were deparaffinised by serial rinsing in 100%
xylene, 100%, 90% and 70% ethanol, and water. Antigen
retrieval was performed by boiling the section in citrate
buffer (pH 6.5) for five minutes. The sections were
covered with Peroxidase Block (DAKO, Carpenteria,
CA) for five minutes and rinsed with Tris-buffered sal-
ine (TBS). Non-specific blocking was performed with
serum-free protein block (DAKO, Carpenteria, CA).
P r i m a r ya n t i b o d yf o rt h ep r o t e i n so fi n t e r e s tw a s
applied to sections with concentrations varying from 1
μg/ml - 4 μg/ml (as titrated in the laboratory, antibody
concentrations and source are provided in Table 1) for
1 hour. Negative slides were treated identically except
isotype control antibody was used instead of primary
antibody. Sections were rinsed and placed in a bath of
TBS containing 0.05% Tween 20 (TBST) and then
incubated with a biotinylated secondary antibody 0.2
μg/ml (DAKO, Carpenteria, CA) for 15 minutes. After
rinsing in TBST, sections were covered with streptavi-
din conjugated to horseradish peroxidise (DAKO,
Table 1 Antibody sources and concentrations used for
immunohistochemistry experiments
Antibody (Abcam) Concentration
Rabbit Polyclonal to FGFR1(ab10646) 1 μg/ml
Rabbit Polyclonal to FGFR2 (ab10648) 4 μg/ml
Rabbit Polyclonal to PDGF-bb (ab23914) 4 μg/ml
Mouse Monoclonal to PDGFRb (ab10847) 4 μg/ml
Mouse Monoclonal to Thrombospondin-1 (ab1823) 4 μg/ml
Rabbit Polyclonal to CD36 (ab36977) 4 μg/ml
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oped using DAB+ chromogen and substrate (DAKO,
Carpenteria, CA) for 5 minutes. Slides were counter-
stained with haematoxylin for three minutes and dehy-
drated in serial washes of increasing ethanol
concentrations (70-100%) followed by xylene. Slides
were examined using a Leica DMLB microscope (Leica
Microsystems Inc., Richmond Hill, ON). Images were
captured using QCapture Pro software (QImaging Cor-
poration, Surrey, BC).
Statistical analysis
Statistical analysis of quantitative RT-PCR was done
using Sigma Stat 3.5 software. Data was logarithmically
transformed before an ANOVA on Ranks test was per-
formed. If the data were normally distributed, and had
equal variance, a one way ANOVA was performed
instead. For ANOVA on Ranks, a Dunn’sp o s tt e s tw a s
u s e d .F o rao n ew a yA N O V A ,aH o l m - S i d a kp o s tt e s t
was used. A p-value < 0.05 was considered significant.
Results
Expression of bFGF, FGFR1, FGFR2 mRNAs level and
immunolocalization
Basic fibroblast growth factor, FGFR1, and FGFR2 were
transcribed in non-pregnant endometrium as well as
endometrium and chorioallantoic membrane at gd20
and 50 (Figure 1). Transcripts of bFGF were higher in
endometrium from arresting conceptus attachment sites
compared to tissue from healthy sites at both gd20, and
gd50 (p < 0.05) (Figure 1A). No significant differences
were found for FGFR1 between endometrial tissue from
healthy and arresting conceptus attachment sites at
either time points (Figure 1B). For FGFR2, endometrial
tissues from arresting conceptus attachment sites had
elevated FGFR2 transcript levels compared to healthy
at gd50 (Figure 1C) (p < 0.05); no difference was seen
at gd20.
Chorioallantoic membrane from arresting conceptus
attachment sites demonstrated elevated transcript levels
of bFGF in comparison with healthy at gd20 (p < 0.05;
Figure 1D). Similarly Chorioallantoic membrane from
arresting gd20 conceptus attachment sites had elevated
transcript levels of FGFR1 and FGFR2 compared to tis-
sue from healthy sites (Figure 1D, E p < 0.05). At gd50,
no significant difference was observed between healthy
and arresting conceptus attachment sites for these three
genes (Figure 1D, E, F).
Fibroblast growth factor receptors 1 and 2 expression
was confirmed in endometrium from healthy and arrest-
ing conceptus attachment sites at gd20 and gd50 by
immunohistochemistry (Figure 2). The receptors were
localized in the endometrial luminal epithelium, blood
vessels, and uterine glands (Figure 2).
Expression of PDGF-bb, PDGFRa, and PDGFRb transcript
levels and immunohistochemistry
Transcript levels of PDGF-bb were higher in endome-
trial tissue from arresting conceptus attachment sites
compared to endometrial tissue from healthy sites at
gd20 (p < 0.05), but were unchanged at gd50 (Figure 3A).
Transcripts for both receptors (PFGFRa and b)w e r e
present in non-pregnant endometrium, endometrium
associated with attachment sites, and gd20 and gd50
chorioallantoic membrane (Figure 3B, C, E, F). No
PDGF-bb transcripts were detected in non-pregnant
endometrium or in gd50 chorioallantoic membrane. An
opposite trend was seen for PDGFRa expression, such
that tissue from healthy conceptus attachment sites had
elevated PDGFRa transcript levels compared to arresting
sites at gd20 (p < 0.05; Figure 3B). Platelet derived growth
factor receptor-b transcript levels did not differ between
endometrium at healthy and arresting conceptus attach-
ment sites (Figure 3C). Platelet Derived Growth Factor
family member transcript levels did not differ between
tissue from healthy and arresting conceptus attachment
sites for gd20 or gd50 chorioallantoic membrane (Figure
3D, E, F).
Platelet derived growth factor-bb and PDGFRb expres-
sion was confirmed in endometrial tissue associated with
healthy and arresting conceptus attachment sites by
immunohistochemistry (Figure 4). Expression of PDGF-
bb was localized to the luminal epithelium, blood
vessels, and uterine glands (Figure 4A, B, D, E). Immu-
nostaining of PDGF-bb appeared more intense in tissue
from arresting conceptus sites at gd20 especially in the
luminal epithelium and in blood vessels (Figure 4A,
and 4B). Platelet Derived Growth Factor Receptor-b was
localized to the luminal epithelium, uterine glands, and
blood vessels (Figure 4G, H, J, K).
Anti-angiogenic factor TSP-1 and its receptor CD36 are
present at the porcine maternal-fetal interface
Both TSP-1 and CD36 were transcribed in non-pregnant
endometrium, as well as in endometrium and chorioal-
lantoic membrane at gd20 and 50 (Figure 5). No differ-
ence was found for transcripts of TSP-1 between
endometrial tissue from healthy and arresting conceptus
attachment sites at gd20 or gd50 (Figure 5A). In endo-
metrium at gd50, arresting conceptus attachment sites
had elevated CD36 transcript levels compared to healthy
s i t e s( p<0 . 0 5 ) ,b u tn od i f f e r e n c ew a sf o u n da tg d 2 0o r
between endometrial samples from non-pregnant and
pregnant pigs (Figure 5B). Thrombospondin-1 transcript
levels were not significantly different between chorioal-
lantoic membrane from healthy and arresting conceptus
attachment sites at gd20 or gd50 (Figure 5C). Chorioal-
lantoic membrane samples from arresting conceptus
attachment sites had elevated transcript levels of CD36
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but not at gd50 (Figure 5D). Both TSP-1 (Figure 6A, B,
D,E) and CD36 (Figure 6G, H, J, K) expression was loca-
lized to the luminal epithelium, uterine glands and
blood vessels.
Discussion
Successful mammalian pregnancy requires a substantial
increase in blood flow at the maternal-fetal interface to
meet the nutrient demands of the growing conceptus.
Various species have evolved various mechanisms to
accomplish this increase in blood flow. In some species,
like human and mice, blood flow is increased by remo-
delling endometrial arteries. In swine, blood flow to the
maternal-fetal interface is increased almost exclusively
by endometrial and placental angiogenesis. Regulation of
angiogenesis and the development of maternal and pla-
cental vasculature are of central importance to optimal
conceptus development. The goal of this study was to
identify and characterize the dynamic changes in angio-
genic growth factor expression at the maternal-fetal
interface during the first half of pregnancy, when preg-
nancy is most likely to fail.
We investigated the FGF and PDGF pro-angiogenic
families. With the exception of PDGFRa, pro-angiogenic
growth factors and receptors transcript levels were ele-
vated at sites of fetal arrest. These findings raise an
intriguing question. Why, at sites of fetal arrest, where it
is well documented that there is reduced vasculature at
the maternal-fetal interface [3,4,7] and pro-angiogenic
molecules (VEGF) are found to be decreased, would
members of other pro-angiogenic families have elevated
transcripts? We postulate that at sites of fetal arrest, the
conceptus responds to signals (or by a dearth of signal)
induced by restricted vascularization, by producing tran-
scripts of the alternate pro-angiogenic molecules bFGF
and PDGFbb,thereby potentially increasing its chances
of survival. This could be a survival mechanism to com-
pensate for decreased VEGF at these sites. The increase
in FGFR1 and FGFR2 transcript levels at arresting sites
in chorioallantoic membrane at gd20 could also be
attributed to this compensatory survival mechanism.
Sufficient receptor expression would be necessary to
a l l o wb F G Ft oi n d u c ea n g i o g e n e s i s .T h ee l e v a t e db F G F
transcript levels at these sites could also drive the eleva-
tion in receptor transcript level. In a swine model of
Figure 1 mRNA expression of bFGF and its receptors at the porcine maternal-fetal interface. bFGF (A, D), FGFR1 (B, E), and FGFR2 (C, F)
mRNA transcripts relative to b-actin transcripts were quantified in non-pregnant (NP) endometrium, and gd20 and gd50 endometrium (A, B, C)
and chorioallantoic membrane (D, E, F) from healthy (HE, HCAM) and arresting (AE, ACAM) conceptus attachment sites. Log transformed data
was analyzed by ANOVA, p < 0.05 was considered significant. ACAM: arresting conceptus chorioallantoic membrane; HCAM: healthy conceptus
chorioallantoic membrane; HE; healthy endometrium; AE: arresting endometrium.
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Page 5 of 11Figure 2 Immunohistochemical localization of FGFR1 and FGFR2. FGFR1 (A-F) and FGFR2 (G-L) expression in endometrium from healthy
(A, D, G, J) and arresting (B, E, H, K) conceptus attachment sites at gd20 and gd50. Expression of both receptors was associated with blood
vessels (red arrows), luminal epithelium (blue arrows), and uterine glands (green arrows). Trophoblast (Tr) are visible in some sections. Size bars
represent 100 μm.
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bFGF was able to increase FGFR1 protein expression [31].
BFGF, PDGF-bb and their angiogenic receptors have a
variety of functions at maternal-fetal interface outside of
angiogenesis. They are involved in tissue remodelling
and function as both propagators and effectors of the
inflammatory response [8,17]. The ubiquitous expression
of bFGF, which has been previously localized to the
luminal epithelium, uterine glands, and uterine stromal
cells and corresponding extracellular matrix in pregnant
porcine endometrium [14] provides further evidence
that it has functions outside of angiogenesis at the por-
cine maternal-fetal interface. The increase in bFGF or
PDGF-bb transcript levels seen at arresting attachment
sites may not solely be associated with angiogenesis, but
rather one of the other functions of the molecule such
as tissue remodelling or effectors of an inflammatory
response. Immunohistochemistry was performed to
visualize whether the localization of angiogenic factors
and receptors differed between healthy and arresting
endometrial attachment sites. Despite repeated attempts
with varying antibody concentrations or modifications in
the protocol, we were unable to optimize immunostain-
ing for bFGF. However, FGFR1 and FGFR2 were loca-
lized to the luminal epithelium, uterine stroma, uterine
glands, and blood vessels in endometrium at both
healthy and arresting attachment sites, similar to pre-
vious findings [13]. Similar localization was observed for
PDGF-bb and PDGFRb. The localization of PDGF-bb
and PDGFRb in perivascular areas at sites of fetal arrest,
along with their ample expression in arresting tissues,
indicates that inhibited stabilization of nascent blood
vessels at arresting sites does not contribute to the lack
of vasculature.
Anti-angiogenesis is essential for regulating growth of
nascent blood vessels. To our surprise, TSP-1 transcript
levels did not differ between healthy and arresting in
endometrium or chorioallantoic membrane at gd20 or
gd50. In contrast, the TSP-1 receptor CD36 shows ele-
vated transcription at sites of arrest in gd20 chorioallan-
toic membrane and gd50 endometrium. In the absence of
an increase in ligand (TSP-1), it is difficult to assess the
Figure 3 mRNA expression of PDGF-bb and its receptors at the porcine maternal-fetal interface.P D G F - b b( A ,D ) ,P D G F R a (B, E), and
PDGFRb (C, F) mRNA transcripts were quantified in non-pregnant endometrium and gd20 and gd50 endometrium and chorioallantoic
membrane from healthy (HE, HCAM) and arresting (AE, ACAM) conceptus attachment sites. Transcript levels are relative to b-actin. ND= Not
detected. Data was log transformed before analysis by ANOVA, p < 0.05 were considered significant. ACAM: arresting conceptus chorioallantoic
membrane; HCAM: healthy conceptus chorioallantoic membrane; HE; healthy endometrium; AE: arresting endometrium.
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Page 7 of 11Figure 4 Immunohistochemical localization of PDGF-bb and PDGFRb. PDGF-bb (A-F) and PDGFRb (G-L) expression in endometrium from
healthy (A, D, G, J), and arresting (B, E, H, K) attachment sites at gd20 and 50. Expression of both ligand and receptor was associated with blood
vessels (red arrows), luminal epithelium (blue arrows), and uterine glands (green arrows). Trophoblasts (Tr) are visible in some sections. Size bars
represent 100 μm.
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would have on anti-angiogenic activity. Currently, there
are no reports of constitutive anti-angiogenic activity
for CD36. CD36 is highly expressed on macrophages
and platelets [32], where it also functions as a scaven-
ger receptor, and is involved in the uptake of apoptotic
particles [33]. Previously, we have shown elevated tran-
script levels for FAS/FASL at arresting attachment sites
during peri-attachment, indicating the possibility of
increased apoptosis [3]. If CD36 is elevated at arresting
sites, it could be related to apoptosis and not anti-
angiogenic activity. But a role in anti-angiogenesis is
strongly suggested, since both TSP-1 and CD36 were
localized to perivascular areas by immunohistochemis-
try. These observations point out potential anti-
angiogenic mechanisms at play at the porcine mater-
nal-fetal interface, but there is insufficient evidence to
suggest that abnormal anti-angiogenic activity contri-
butes to fetal arrest.
This study provides insight into the changes of
pro-angiogenic growth factor expression during the first
half of pregnancy in a species with epitheliochorial pla-
centation. It also demonstrates for the first time that
anti-angiogenic growth factors are abundantly present
particularly at arresting sites at the maternal-fetal inter-
face during porcine pregnancy.
Figure 5 mRNA expression of TSP-1 and CD36 at the porcine maternal-fetal interface. TSP-1 (A), and CD36 (B) mRNA transcripts in non-
pregnant endometrium and gd20 and gd50 endometrium (A,C) and chorioallantoic membrane (B, D) were quantified from healthy (HE, HCAM)
and arresting (AE, ACAM) conceptus attachment sites. Transcript levels are relative to b-actin. Data was log transformed and analyzed by ANOVA.
A p < 0.05 was considered significant. ACAM: arresting conceptus chorioallantoic membrane; HCAM: healthy conceptus chorioallantoic
membrane; HE; healthy endometrium; AE: arresting endometrium.
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Page 9 of 11Figure 6 Immunohistochemical localization of TSP-1 and CD36. TSP-1 (A-F) and CD36 (G-L) were immunolocalized in endometrium at
healthy (A, D) and arresting (B, E) conceptus attachment sites gd20 and 50. Expression of ligand and receptor was localized to blood vessels
(red arrows), luminal epithelium (blue arrows), and uterine glands (green arrow). Size bars represent 100 μm.
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